Tobias Kessler

Heidelberg, BW, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 83 publications

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

Loss of MSH6 or MSH2 sensitizes progressive glioblastoma to radiotherapy.

Journal: The Journal of clinical investigation

Published: August 25, 2026

An online decision aid for patients with prostate cancer evaluating local treatment options reduces decisional conflict and distress and improves knowledge: Postmarket surveillance in German routine care.

An online decision aid for patients with prostate cancer evaluating local treatment options reduces decisional conflict and distress and improves knowledge: Postmarket surveillance in German routine care.

Journal: World journal of urology

Published: December 09, 2025

MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma.

MGMT promoter methylation modulates the effect of residual tumor on survival after re-resection of recurrent glioblastoma.

Journal: Acta neuropathologica communications

Published: December 06, 2025

Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients.

Spatial Transcriptomics Characterisation of Radionecrotic Changes in Glioblastoma Patients.

Journal: Neuro-oncology

Published: September 05, 2025

Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients.

Spatial transcriptomics characterisation of radionecrotic changes in glioblastoma patients.

Journal: Neuro-oncology

Published: September 05, 2025

Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas.

Early distant progression in adult Histone-3 K27-altered diffuse midline gliomas.

Journal: Journal of neuro-oncology

Published: September 05, 2025

Multimodality mapping of immunotherapy distribution as a predictive marker in glioma.

Multimodality mapping of immunotherapy distribution as a predictive marker in glioma.

Journal: Neuro-oncology

Published: August 15, 2025

A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct.

A comparative analysis of CD70-directed CAR-T cells for glioblastoma treatment demonstrates a superior efficacy of the ligand-based construct.

Journal: Molecular therapy. Oncology

Published: August 04, 2025

Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.

Utilization of universal-targeting mSA2 CAR-T cells for the treatment of glioblastoma.

Journal: Oncoimmunology

Published: June 16, 2025

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.

Histopathological and molecular characteristics of IDH-wildtype glioblastoma without contrast enhancement: Implications for clinical outcomes.

Journal: Neuro-oncology

Published: March 20, 2025

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.

Respiratory function in 192 adult patients with spinal muscular atrophy (SMA) treated with nusinersen - a multicenter observational study.

Journal: Orphanet journal of rare diseases

Published: February 23, 2025

Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen.

Long-Term Dynamics of CSF and Serum Neurofilament Light Chain in Adult Patients With 5q Spinal Muscular Atrophy Treated With Nusinersen.

Journal: Neurology

Published: February 13, 2025

Showing 1-12 of 83

Last Updated: 09/26/2026